162 related articles for article (PubMed ID: 28072620)
1. Fibrous Dysplasia Mimicking Malignancy on 68Ga-DOTATATE PET/CT.
Papadakis GZ; Millo C; Sadowski SM; Karantanas AH; Bagci U; Patronas NJ
Clin Nucl Med; 2017 Mar; 42(3):209-210. PubMed ID: 28072620
[TBL] [Abstract][Full Text] [Related]
2. Breast Fibroadenoma With Increased Activity on 68Ga DOTATATE PET/CT.
Papadakis GZ; Millo C; Sadowski SM; Karantanas AH; Bagci U; Patronas NJ
Clin Nucl Med; 2017 Feb; 42(2):145-146. PubMed ID: 27879489
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors.
Panagiotidis E; Alshammari A; Michopoulou S; Skoura E; Naik K; Maragkoudakis E; Mohmaduvesh M; Al-Harbi M; Belda M; Caplin ME; Toumpanakis C; Bomanji J
J Nucl Med; 2017 Jan; 58(1):91-96. PubMed ID: 27516446
[TBL] [Abstract][Full Text] [Related]
5. Polyostotic Fibrous Dysplasia in McCune-Albright Syndrome Demonstrated on 68Ga-DOTATATE PET/CT.
Hennessy G; Shetty D; Loh H; Bui C; Le K; Mansberg R
Clin Nucl Med; 2016 Dec; 41(12):982-985. PubMed ID: 27740949
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular Carcinoma Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE PET/CT.
Ulaner GA; Bodei L
Clin Nucl Med; 2019 Apr; 44(4):330-331. PubMed ID: 30688738
[TBL] [Abstract][Full Text] [Related]
7. Optimizing Somatostatin Receptor Imaging in Patients With Neuroendocrine Tumors: The Impact of 99mTc-HYNICTOC SPECT/SPECT/CT Versus 68Ga-DOTATATE PET/CT Upon Clinical Management.
Kunikowska J; Lewington V; Krolicki L
Clin Nucl Med; 2017 Dec; 42(12):905-911. PubMed ID: 29076910
[TBL] [Abstract][Full Text] [Related]
8. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
Sampathirao N; Basu S
J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
[TBL] [Abstract][Full Text] [Related]
9. ACR Practice Parameter for the Performance of Gallium-68 DOTATATE PET/CT for Neuroendocrine Tumors.
Subramaniam RM; Bradshaw ML; Lewis K; Pinho D; Shah C; Walker RC
Clin Nucl Med; 2018 Dec; 43(12):899-908. PubMed ID: 30394933
[TBL] [Abstract][Full Text] [Related]
10. Schmorl Nodes Can Cause Increased 68Ga DOTATATE Activity on PET/CT, Mimicking Metastasis in Patients With Neuroendocrine Malignancy.
Papadakis GZ; Millo C; Bagci U; Sadowski SM; Stratakis CA
Clin Nucl Med; 2016 Mar; 41(3):249-50. PubMed ID: 26562580
[TBL] [Abstract][Full Text] [Related]
11. A frequency and semiquantitative analysis of pathological 68Ga DOTATATE PET/CT uptake by primary site-dependent neuroendocrine tumor metastasis.
Kunikowska J; Pawlak D; Kolasa A; Mikołajczak R; Królicki L
Clin Nucl Med; 2014 Oct; 39(10):855-61. PubMed ID: 25072928
[TBL] [Abstract][Full Text] [Related]
12. Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor.
Chan M; Schembri GP
Clin Nucl Med; 2017 Feb; 42(2):108-109. PubMed ID: 27997429
[TBL] [Abstract][Full Text] [Related]
13. Head-to-Head Comparison of
Johnbeck CB; Knigge U; Loft A; Berthelsen AK; Mortensen J; Oturai P; Langer SW; Elema DR; Kjaer A
J Nucl Med; 2017 Mar; 58(3):451-457. PubMed ID: 27660147
[TBL] [Abstract][Full Text] [Related]
14. A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice.
Aalbersberg EA; Geluk-Jonker MM; Young-Mylvaganan T; de Wit-van der Veen LJ; Stokkel MPM
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058910
[TBL] [Abstract][Full Text] [Related]
15. 68Ga-DOTATATE Uptake in Pancreatic Metastasis of Renal Cell Carcinoma Mimicking Pancreatic Neuroendocrine Tumor.
Soydal C; Nak D; Araz M; Demirkazik A; Kucuk NO
Clin Nucl Med; 2019 Oct; 44(10):795-796. PubMed ID: 31306201
[TBL] [Abstract][Full Text] [Related]
16. Brain Metastases of a Neuroendocrine Tumor Visualized by 68Ga-DOTATATE PET/CT.
Hoberück S; Michler E; Zöphel K; Platzek I; Kotzerke J; Brogsitter C
Clin Nucl Med; 2019 Jan; 44(1):50-52. PubMed ID: 30371585
[TBL] [Abstract][Full Text] [Related]
17. Evolution of a Schmorl's Node and a Degenerative Osteophyte on Sequential 68Ga-DOTATATE PET/CT Scans: Potential Pitfalls in Neuroendocrine Tumor Imaging.
Hod N; Levin D; Anconina R; Benkovich E; Ezroh Kazap D; Lantsberg S
Clin Nucl Med; 2019 Jan; 44(1):e40-e42. PubMed ID: 30418207
[TBL] [Abstract][Full Text] [Related]
18. 68Ga-DOTATATE PET/CT in Primary Hepatic Neuroendocrine Tumor.
Gorla AK; Basher RK; Kaman L; Bal A; Bhattacharya A; Mittal BR
Clin Nucl Med; 2017 Feb; 42(2):118-120. PubMed ID: 28005645
[TBL] [Abstract][Full Text] [Related]
19. Increased Activity Due to Fractures Does Not Significantly Affect the Accuracy of 68Ga-DOTATATE PET/CT in the Detection of Culprit Tumor in the Evaluation of Tumor-Induced Osteomalacia.
Ding J; Hu G; Wang L; Li F; Huo L
Clin Nucl Med; 2018 Dec; 43(12):880-886. PubMed ID: 30273206
[TBL] [Abstract][Full Text] [Related]
20. 68Ga DOTATATE PET/CT of Non-FDG-Avid Pulmonary Metastatic Hemangiopericytoma.
Hung TJ; Macdonald W; Muir T; Celliers L; Al-Ogaili Z
Clin Nucl Med; 2016 Oct; 41(10):779-80. PubMed ID: 27454598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
